May 27, 2026 04:05AM
May 27, 2026 02:30AM
May 21, 2026 07:01AM
May 14, 2026 07:01AM
May 14, 2026 07:01AM
May 5, 2026 07:01AM
Apr 29, 2026 07:01AM Precision BioSciences begins patient enrollment in DMD gene editing trial
Apr 29, 2026 07:01AM
Apr 28, 2026 07:01AM
Apr 28, 2026 07:01AM
Apr 22, 2026 07:01AM
Apr 15, 2026 07:02AM
Apr 15, 2026 07:01AM
Mar 18, 2026 08:00AM iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission
Mar 12, 2026 07:00AM
Mar 11, 2026 07:01AM
Mar 11, 2026 07:01AM
Mar 10, 2026 07:01AM
Mar 10, 2026 07:01AM
Mar 9, 2026 07:01AM
Mar 9, 2026 07:01AM Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event
Feb 18, 2026 07:01AM
Feb 11, 2026 07:01AM
Feb 11, 2026 07:01AM
Jan 12, 2026 07:03AM
Jan 12, 2026 07:01AM
Jan 7, 2026 08:00AM
Nov 10, 2025 05:22PM Precision BioSciences shows positive early results for hepatitis B gene therapy
Nov 10, 2025 05:21PM
Nov 3, 2025 07:01AM
Aug 7, 2025 07:01AM
Jul 23, 2025 07:02AM
Jul 23, 2025 07:01AM
Jul 17, 2025 12:10PM
Jun 25, 2025 07:03AM Precision BioSciences (DTIL) Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
Jun 25, 2025 07:01AM
May 15, 2025 07:01AM
May 7, 2025 07:01AM
Apr 15, 2025 07:01AM
Apr 15, 2025 07:01AM
Mar 26, 2025 07:01AM
Mar 20, 2025 07:01AM Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025
Mar 17, 2025 07:02AM
Mar 17, 2025 07:01AM
Aug 9, 2024 07:01AM
Aug 1, 2024 07:15AM
Jun 20, 2024 07:00AM
May 13, 2024 07:00AM
May 7, 2024 08:30AM Precision BioSciences (DTIL) Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency
May 7, 2024 08:30AM

322,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All